Patents by Inventor Roli Khattri

Roli Khattri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-1 Binding Proteins and Methods of Use Thereof
    Publication number: 20230272076
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: August 1, 2022
    Publication date: August 31, 2023
    Inventors: Brydon Bennett, Philip P. Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
    Publication number: 20210069325
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: July 31, 2020
    Publication date: March 11, 2021
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • Methods of treating psoriasis using PD-1 binding antibodies
    Patent number: 10751414
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: August 25, 2020
    Assignee: Celgene Corporation
    Inventors: Henry H. Chan, Eun Mi Hur, Roli Khattri, Monica Leung, Garth E. Ringheim, Peter H. Schafer
  • PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20200255525
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 17, 2019
    Publication date: August 13, 2020
    Inventors: Brydon Bennett, Philip P. Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • PD-1 binding proteins and methods of use thereof
    Patent number: 10428145
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: October 1, 2019
    Assignee: Celgene Corporation
    Inventors: Brydon Bennett, Philip Paul Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • METHODS OF TREATING IMMUNE DISORDERS USING PD-1 BINDING PROTEINS
    Publication number: 20180092975
    Abstract: Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 18, 2017
    Publication date: April 5, 2018
    Inventors: Henry H. CHAN, Eun Mi HUR, Roli KHATTRI, Monica LEUNG, Garth E. RINGHEIM, Peter H. SCHAFER
  • PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20170088618
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
    Type: Application
    Filed: September 28, 2016
    Publication date: March 30, 2017
    Inventors: Brydon Bennett, Philip Paul Chamberlain, Kandasamy Hariharan, Pilgrim Jackson, Marilyn Kehry, Roli Khattri, Monica Leung, Lisa Morrison, Jeonghoon Sun, Sanaa Torres, Henry H. Chan
  • Method for regulating immune function in primates using the Foxp3 protein
    Publication number: 20090169543
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin and proteins that induce or inhibit Foxp3 expression.
    Type: Application
    Filed: November 6, 2008
    Publication date: July 2, 2009
    Applicant: UCB SA
    Inventors: Roli Khattri, Mary E. Brunkow, Fred Ramsdell
  • Method for regulating immune function using the FOXP3 protein
    Patent number: 7507542
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin (Fkhsf) and proteins that induce or inhibit Scurfin or Foxp3 expression.
    Type: Grant
    Filed: May 8, 2002
    Date of Patent: March 24, 2009
    Assignee: UCB SA
    Inventors: Roli Khattri, Mary E Brunkow, Fred Ramsdell
  • Method for regulating immune function in primates using the Foxp3 protein
    Publication number: 20030170648
    Abstract: Isolated nucleic acid molecules are provided which encode Fkhsf, as well as mutant forms thereof. Also provided are expression vectors suitable for expressing such nucleic acid molecules, and host cells containing such expression vectors. Also provided are pharmaceutical compounds and methods of identifying such compounds that can modulate the immune system. In addition are provided methods for identifying proteins regulated by Scurfin and proteins that induce or inhibit Foxp3 expression.
    Type: Application
    Filed: May 8, 2002
    Publication date: September 11, 2003
    Applicant: Darwin Molecular Corporation
    Inventors: Roli Khattri, Mary E. Brunkow, Fred Ramsdell